Partial replacement of the tricuspid valve by mitral homografts in acute endocarditis

Couëtil, Jean-Paul; Argyriadis, Pantelis G.; Shafy, Abdel; Cohen, Ariel; Berrébi, Alain; Loulmet, Didier F.; Chachques, Juan-Carlos; Carpentier, Alain

doi:10.1016/s0003-4975(02)03574-9

Cited by 29 publications

(15 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…More recently, there is report of a mitral valve homograft being used to replace the tricuspid valve. Couetil et al 5 reported recently on seven patients with acute tricuspid endocarditis. All patients underwent resection of the anterior and posterior leaflets of the valve with their corresponding papillary muscles, leaving the septal leaflet in place as this leaflet remained unaffected.…”

Section: Discussionmentioning

confidence: 99%

“…Vegectomy and resection of the base of implantation of the vegetation on the leaflet followed by pericardial patch repair is recommended. 5 If the feasibility of repair is significantly diminished by the degree of destruction to the subvalvular apparatus of the anterior leaflet of the valve, and since the septal leaflet is almost never involved, then a mitral homograft can be used.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Tricuspid valvectomy: Long-term survival and surgical options

Chait

Midwall

2006

Clin Cardiol

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Tricuspid valvectomy: Long-term survival and surgical options

Chait

Midwall

2006

Clin Cardiol

View full text Add to dashboard Cite

show abstract

“…Tokunaga et al reported excellent long-term outcomes with isolated TVR in 31 patients with tricuspid valve disease whose operative mortality was 6.5% [9]. A partial replacement using a mitral homograft has been reported by Couetil et al [10]. Morokuma et al have reported the three cases with isolated TVIE and the surgical results.…”

Section: Discussionmentioning

confidence: 94%

Isolated tricuspid valve infective endocarditis in young drug abusers

Ozkara¹,

Faruk²,

Furat³

2012

WJCD

View full text Add to dashboard Cite

Isolated tricuspid valve infective endocarditis (TVIE) is a rare clinical condition. Thus, there is no common consensus for the treatment options for TVIE. Vegetectomy and valvulectomy, valve repair, and valve replacement, which are controversial in regard to hemodynamic consequences in right-sided low-pressure system and long-term prognosis. We present 2 young intravenous drug users with TVIE and our surgical strategy.

show abstract

“…However, the durability of new bioprosthetic valves have improved over the years as recent data suggest no difference in long term data between bioprosthetic and mechanical valves at 15 years [20]. Additionally, mitral homografts have been used in the tricuspid space but with limited experience and long-term data [21].…”

Section: Valve Choice With Replacementmentioning

confidence: 99%

Contemporary and Evolving Treatment of Tricuspid Endocarditis

Ayzenbart¹

2021

Advanced Concepts in Endocarditis - 2021

View full text Add to dashboard Cite

The current treatment paradigm for right sided infective endocarditis is rapidly evolving. The existing recommendations for right sided infective endocarditis include medical therapy with surgical therapy used in certain situations. Surgical therapy is based on the size of the vegetation, presence of infective complications and certain causative organisms as well the retention of intracardiac devices. Unfortunately, medical therapy alone is usually not enough to clear the infection, especially when intravenous drug use is associated as the etiology. Intravenous drug use is associated with a high rate of recidivism in tricuspid valve endocarditis. Even with indications for surgery, these patients present an ethical dilemma as most of these patients will re-infect their valves post-surgery. This often provides little option than for the surgeon to re-operate in a setting with a higher risk of mortality and morbidity. We present an evolving technique of percutaneous extirpation of vegetation, allowing for rapid clearance of endocarditis, less chance of failure of medical therapy with a lower risk profile for complication.

show abstract

Partial replacement of the tricuspid valve by mitral homografts in acute endocarditis

Cited by 29 publications

References 17 publications

Tricuspid valvectomy: Long-term survival and surgical options

Tricuspid valvectomy: Long-term survival and surgical options

Isolated tricuspid valve infective endocarditis in young drug abusers

Contemporary and Evolving Treatment of Tricuspid Endocarditis

Contact Info

Product

Resources

About